Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02017964 · OUTCOME

Percentage of Patients With Responses at 273 Days

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma · Source last updated 2023-01-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage of patients
Interval / dispersion
95% Confidence Interval
Time frame
273 days from start of treatment

What was measured

The percentage of patients with complete response (CR) at the end of therapy (\~273 days) was reported and presented with the associated exact 95% confidence interval.

Analysis population: 26 patients were enrolled on the protocol, but 1 was deemed ineligible. The ineligible patient is excluded from all analyses.

Groups in this outcome

All Eligible Patients (Combination Chemotherapy)

All eligible patients enrolled on the study

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Eligible Patients (Combination Chemotherapy)25

Reported measurements

Source class 1
Values in Percentage of patients · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
All Eligible Patients (Combination Chemotherapy)88.0Not reported69.796.7Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        69.7
        upper Limit
        96.7
        value
        88.0
denoms
  1. counts
    1. group Id
      OG000
      value
      25
    units
    Participants
description
The percentage of patients with complete response (CR) at the end of therapy (\~273 days) was reported and presented with the associated exact 95% confidence interval.
dispersion Type
95% Confidence Interval
groups
  1. description
    All eligible patients enrolled on the study
    id
    OG000
    title
    All Eligible Patients (Combination Chemotherapy)
param Type
NUMBER
population Description
26 patients were enrolled on the protocol, but 1 was deemed ineligible. The ineligible patient is excluded from all analyses.
reporting Status
POSTED
time Frame
273 days from start of treatment
title
Percentage of Patients With Responses at 273 Days
type
PRIMARY
unit Of Measure
Percentage of patients

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice